Dendritic cell vaccines for high-grade gliomas
Matthew E Eagles,1 Farshad Nassiri,2,3 Jetan H Badhiwala,2 Suganth Suppiah,2 Saleh A Almenawer,4 Gelareh Zadeh,3,5 Kenneth D Aldape3,6 1Section of Neurosurgery, Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada; 2Division of Neurosurgery, Department of Surgery, Univer...
Main Authors: | Eagles ME, Nassiri F, Badhiwala JH, Suppiah S, Almenawer SA, Zadeh G, Aldape KD |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-07-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/dendritic-cell-vaccines-for-high-grade-gliomas-peer-reviewed-article-TCRM |
Similar Items
-
Ready for Prime Time? Dendritic Cells in High-Grade Gliomas
by: Claire A. Conarroe, et al.
Published: (2023-05-01) -
Dendritic cell vaccine of gliomas: challenges from bench to bed
by: Ye Zheng, et al.
Published: (2023-09-01) -
Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
by: Angeliki Datsi, et al.
Published: (2021-11-01) -
The application of dendritic cells vaccination in malignant glioma
by: Hong⁃yu LIU, et al.
Published: (2020-02-01) -
Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
by: Jing Zhou, et al.
Published: (2023-03-01)